IN8bio, Inc. (INAB)
1.09
-0.05
(-4.39%)
USD |
NASDAQ |
Sep 09, 12:39
IN8bio 1 Year Total Returns (Daily) : -47.22% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | -47.22% |
| September 04, 2026 | -44.95% |
| September 03, 2026 | -47.63% |
| September 02, 2026 | -50.23% |
| September 01, 2026 | -50.68% |
| August 31, 2026 | -50.23% |
| August 28, 2026 | -54.20% |
| August 27, 2026 | -54.39% |
| August 26, 2026 | -47.10% |
| August 25, 2026 | -46.58% |
| August 24, 2026 | -47.79% |
| August 21, 2026 | -42.86% |
| August 20, 2026 | -45.25% |
| August 19, 2026 | -47.37% |
| August 18, 2026 | -52.30% |
| August 17, 2026 | -53.16% |
| August 14, 2026 | -54.17% |
| August 13, 2026 | -48.47% |
| August 12, 2026 | -55.62% |
| August 11, 2026 | -53.74% |
| August 10, 2026 | -57.75% |
| August 07, 2026 | -54.48% |
| August 06, 2026 | -53.81% |
| August 05, 2026 | -54.43% |
| August 04, 2026 | -54.06% |
| Date | Value |
|---|---|
| August 03, 2026 | -54.50% |
| July 31, 2026 | -51.41% |
| July 30, 2026 | -49.77% |
| July 29, 2026 | -51.36% |
| July 28, 2026 | -52.77% |
| July 27, 2026 | -51.23% |
| July 24, 2026 | -50.21% |
| July 23, 2026 | -51.63% |
| July 22, 2026 | -48.10% |
| July 21, 2026 | -46.09% |
| July 20, 2026 | -41.94% |
| July 17, 2026 | -39.55% |
| July 16, 2026 | -37.27% |
| July 15, 2026 | -33.49% |
| July 14, 2026 | -37.84% |
| July 13, 2026 | -41.48% |
| July 10, 2026 | -41.92% |
| July 09, 2026 | -43.78% |
| July 08, 2026 | -37.27% |
| July 07, 2026 | -33.81% |
| July 06, 2026 | -33.94% |
| July 02, 2026 | -34.26% |
| July 01, 2026 | -31.40% |
| June 30, 2026 | -32.54% |
| June 29, 2026 | -32.86% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 213.2% |
| Oncolytics Biotech, Inc. | -37.11% |
| Sangamo Therapeutics, Inc. | -69.35% |
| Sarepta Therapeutics, Inc. | 18.98% |
| Anixa Biosciences, Inc. | -2.68% |